73 related articles for article (PubMed ID: 38566143)
1. Expanding the possibilities of using sodium-glucose cotransporter 2 inhibitors in patients with heart failure.
Rоsul ММ; М Bletskan М; Ivano NV; Rudakova SO
Wiad Lek; 2024; 77(3):585-590. PubMed ID: 38691804
[TBL] [Abstract][Full Text] [Related]
2. SGLT2 inhibition, venous thrombolism, and death due to cardiac causes: a mediation Mendelian randomization study.
Shi L; Wei X; Luo J; Tu L
Front Cardiovasc Med; 2024; 11():1339094. PubMed ID: 38803667
[TBL] [Abstract][Full Text] [Related]
3. SGLT2 inhibition, circulating proteins, and insomnia: A mendelian randomization study.
Luo J; Tu L; Zhou C; Li G; Shi L; Hu S
Sleep Med; 2024 May; 119():480-487. PubMed ID: 38795402
[TBL] [Abstract][Full Text] [Related]
4. Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
Rao S
Adv Ther; 2022 Feb; 39(2):845-861. PubMed ID: 34881413
[TBL] [Abstract][Full Text] [Related]
5. Exploring the potential causal relationship between gut microbiota and heart failure: A two-sample mendelian randomization study combined with the geo database.
Pang S; Han T; Huang X; Zhao Y; Qian J; Zhong J; Xie P; Liao L
Curr Probl Cardiol; 2024 Feb; 49(2):102235. PubMed ID: 38040216
[TBL] [Abstract][Full Text] [Related]
6. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
[TBL] [Abstract][Full Text] [Related]
7. Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.
Wang H; Guo Z; Zheng Y; Chen B
BMC Cardiovasc Disord; 2022 Jun; 22(1):262. PubMed ID: 35690714
[TBL] [Abstract][Full Text] [Related]
8. Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study.
Habibi D; Daneshpour MS; Asgarian S; Kohansal K; Hadaegh F; Mansourian M; Akbarzadeh M
BMC Cardiovasc Disord; 2023 Mar; 23(1):112. PubMed ID: 36882679
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis.
Li X; Chan JSK; Guan B; Peng S; Wu X; Lu X; Zhou J; Hui JMH; Lee YHA; Satti DI; Tsang SL; Wu S; Chen S; Tse G; Liu S
Cardiovasc Diabetol; 2022 Nov; 21(1):229. PubMed ID: 36329456
[TBL] [Abstract][Full Text] [Related]
10. Genetically Determined Inflammatory Biomarkers and the Risk of Heart Failure: A Mendelian Randomization Study.
Li X; Peng S; Guan B; Chen S; Zhou G; Wei Y; Gong C; Xu J; Lu X; Zhang X; Liu S
Front Cardiovasc Med; 2021; 8():734400. PubMed ID: 34881299
[No Abstract] [Full Text] [Related]
11. Mendelian randomization for cardiovascular diseases: principles and applications.
Larsson SC; Butterworth AS; Burgess S
Eur Heart J; 2023 Dec; 44(47):4913-4924. PubMed ID: 37935836
[TBL] [Abstract][Full Text] [Related]
12. SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study.
Li J; Yu Y; Sun Y; Yu B; Tan X; Wang B; Lu Y; Wang N
Cardiovasc Diabetol; 2023 Oct; 22(1):278. PubMed ID: 37848934
[TBL] [Abstract][Full Text] [Related]
13. Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma.
Wang Q; Shi Q; Wang Z; Lu J; Hou J
BMC Med; 2023 Sep; 21(1):377. PubMed ID: 37775746
[TBL] [Abstract][Full Text] [Related]
14. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.
Zhao JH; Stacey D; Eriksson N; Macdonald-Dunlop E; Hedman ÅK; Kalnapenkis A; Enroth S; Cozzetto D; Digby-Bell J; Marten J; Folkersen L; Herder C; Jonsson L; Bergen SE; Gieger C; Needham EJ; Surendran P; ; Paul DS; Polasek O; Thorand B; Grallert H; Roden M; Võsa U; Esko T; Hayward C; Johansson Å; Gyllensten U; Powell N; Hansson O; Mattsson-Carlgren N; Joshi PK; Danesh J; Padyukov L; Klareskog L; Landén M; Wilson JF; Siegbahn A; Wallentin L; Mälarstig A; Butterworth AS; Peters JE
Nat Immunol; 2023 Sep; 24(9):1540-1551. PubMed ID: 37563310
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
